Yahoo Web Search

Search results

  1. en.wikipedia.org › wiki › Yan_MooreYan Moore - Wikipedia

    Yan Moore (born February 6, 1953) is a Canadian television writer and producer. He is best known as a writer for Degrassi Junior High, Degrassi High and Degrassi: The Next Generation. He was also the creator and producer of the Canadian soap opera Riverdale (1997–2000).

  2. Jan 10, 2022 · Omega Therapeutics Announces Appointment of Yan Moore, M.D., as Chief Medical Officer. January 10, 2022. PDF Version. Industry Veteran With Over Two Decades of Drug Development Experience Will Shepherd the Company's Transition Into the Clinic.

  3. Apr 1, 2020 · View Yan Moore, MD, MBA’s profile on LinkedIn, a professional community of 1 billion members.

    • 500+
    • 3.4K
  4. Jan 10, 2022 · Yan Moore, M.D., Omega Therapeutics, Inc. (Nasdaq: OMGA), a development-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as a new class of programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programing platform, today announced the appointment of Yan Moore, M.D., as Chief Medical ...

  5. Dr. Yan Moore joined Omega as Chief Medical Officer in January 2022. Prior to Omega, he served as Senior Vice President, Head of Oncology Therapeutic Area at Ipsen Pharmaceuticals, and before that as Chief Medical Officer and Senior Vice President of Clinical Development and Research and Development at Anchiano Therapeutics (previously ...

    • Chief Medical Officer
    • Omega Therapeutics, Omega Therapeutics
  6. Yan Moore, MD, MBA 8mo Report this post Our ASCO poster is up and for the first time ever we demonstrate how our drug in combination with CPI (anti PD-1 or anti PD-L1) significantly reduce tumor ...

  7. Dr. Yan Moore joined Omega as Chief Medical Officer in January 2022. Prior to Omega, he served as Senior Vice President, Head of Oncology Therapeutic Area at Ipsen Pharmaceuticals, and before that as Chief Medical Officer and Senior Vice President of Clinical Development and Research and Development at Anchiano Therapeutics (previously BioCanCell

  1. People also search for